COVID-19 Merck pill works against variants, research shows
Research shows that the experimental antiviral drug molnupiravir is likely to be effective against known COVID-19 strains.
The Merck logo is seen at a gate to the Merck & Co campus in Rahway, New Jersey, US, July 12, 2018. (photo credit: REUTERS/BRENDAN MCDERMID)